Cargando…
CD24 Gene Expression as a Risk Factor for Non-Alcoholic Fatty Liver Disease
In light of increasing NAFLD prevalence, early detection and diagnosis are needed for decision-making in clinical practice and could be helpful in the management of patients with NAFLD. The goal of this study was to evaluate the diagnostic accuracy of CD24 gene expression as a non-invasive tool to d...
Autores principales: | Amin, Mona A., Ragab, Halla M., Abd El Maksoud, Nabila, Elaziz, Wafaa Abd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000766/ https://www.ncbi.nlm.nih.gov/pubmed/36900128 http://dx.doi.org/10.3390/diagnostics13050984 |
Ejemplares similares
-
Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
por: Ragab, Halla M., et al.
Publicado: (2023) -
Significance of growth differentiation factor 15 in chronic HCV patients
por: Halim, Mohab H., et al.
Publicado: (2017) -
Assessment of Ki-67 as a potential biomarker in patients with breast cancer
por: Ragab, Halla Mohamed, et al.
Publicado: (2018) -
New Era for Usage of Serum Liver Enzymes as A Promising Horizon for the Prediction of Non-Alcoholic Fatty Liver Disease
por: Salman, Ahmed Abd Allah, et al.
Publicado: (2016) -
Mac-2 binding protein in non-alcoholic fatty liver disease: Is it a reliable diagnostic biomarker? A pilot study
por: El-Aziz, Rokaya Abd, et al.
Publicado: (2020)